Efluelda TIV 0.5 mL, suspension injectable en seringue pré-remplie

7680698630050 CH-69863 suspension

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/05/2026
Summary of Product Characteristics
Français
27/05/2026
Summary of Product Characteristics
Italien
27/05/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
60.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
60.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
60.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
natrii dihydrogenophosphas anhydricus
- Substance HNIDK
octoxinolum-9
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.96 MG Substance HBESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
69863
Drug name
Efluelda TIV, suspension injectable en seringue pré-remplie
Galenic form
SUPAS
ATC Code
J07BB02
Authorization status
Z
Dispensing category
B
First authorization
07/04/2025
Authorization expiration date
06/04/2030
IT Number
08.08.
Domain
Human medicine

Package details

Description (FR)
EFLUELDA TIV 0.5 mL susp inj 60 µg 1 pce
Description (DE)
EFLUELDA TIV 0.5 mL Inj Susp 60 µg 1 Stk
Market launch
09/04/2026
Narcotic (BTM)
No

Other package sizes (5)

None
1 FESP
GTIN: None
Not in V1
None
10 FESP
GTIN: None
Not in V1
EFLUELDA TIV 0.5 mL susp inj 60 µg 1 pce
1 FESP
GTIN: 7680698630036
View
None
10 FESP
GTIN: None
Not in V1
None
10 FESP
GTIN: None
Not in V1
Buy us a coffee Explore the data